J V Menani Selected Research

pyrrolidonyl-beta-naphthylamide

8/2015	Sodium intake combining cholinergic activation and noradrenaline into the lateral parabrachial nucleus.
4/2012	Moxonidine into the lateral parabrachial nucleus reduces renal and hormonal responses to cell dehydration.
1/2003	Brain serotonin blockade and paradoxical salt intake in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J V Menani Research Topics

Disease

8	Body Weight (Weight, Body) 08/2015 - 09/2002
5	Hypertension (High Blood Pressure) 01/2019 - 05/2000
4	Hypotension (Low Blood Pressure) 12/2013 - 07/2005
4	Dehydration (Water Stress) 04/2012 - 01/2003
2	Obesity 03/2016 - 03/2015
2	Hypercapnia 04/2015 - 05/2014
2	Bradycardia 10/2013 - 07/2005
1	Essential Hypertension 01/2022
1	Chronic Disease (Chronic Diseases) 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 03/2015
1	Insulin Resistance 03/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2015
1	Dyslipidemias (Dyslipidemia) 03/2015
1	Hyperglycemia 03/2015
1	Hemorrhage 12/2013
1	Hypothermia 07/2011
1	Hyperthermia 07/2011
1	Hypoxia (Hypoxemia) 03/2011
1	Tachycardia (Tachyarrhythmias) 08/2007

Drug/Important Bio-Agent (IBA)

5	SodiumIBA 01/2019 - 01/2003
4	LeptinIBA 03/2016 - 05/2014
3	Pilocarpine (Ocusert)FDA LinkGeneric 08/2015 - 09/2002
3	pyrrolidonyl-beta-naphthylamideIBA 08/2015 - 01/2003
3	salicylhydroxamic acid (SHAM)IBA 12/2013 - 08/2007
2	Losartan (Cozaar)FDA LinkGeneric 12/2013 - 09/2002
2	moxonidine (Moxon)IBA 10/2013 - 04/2012
1	Estrogens (Estrogen)FDA Link 01/2022
1	SaltsIBA 01/2019
1	Hormones (Hormone)IBA 03/2016
1	Prazosin (Minipress)FDA LinkGeneric 08/2015
1	NestinIBA 04/2015
1	SHU 9119IBA 04/2015
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2015
1	Leptin ReceptorsIBA 03/2015
1	Type 1 Angiotensin ReceptorIBA 12/2013
1	Therapeutic UsesIBA 10/2013
1	2-methoxyidazoxanIBA 07/2011
1	Yohimbine (Yocon)IBA 07/2011
1	Sodium CyanideIBA 03/2011
1	Adenosine Triphosphate (ATP)IBA 01/2009
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2009
1	4- diphenylacetoxy- 1,1- dimethylpiperidiniumIBA 12/2008
1	Cholinergic ReceptorsIBA 12/2008
1	PirenzepineIBA 12/2008
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2008
1	methoctramineIBA 12/2008
1	Tropicamide FDA LinkGeneric 12/2008
1	Ketamine FDA LinkGeneric 12/2008
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 08/2007
1	Atropine FDA LinkGeneric 07/2005
1	Serotonin (5 Hydroxytryptamine)IBA 07/2005
1	MuscimolIBA 07/2005
1	GABA Agonists (GABA Receptor Agonists)IBA 07/2005
1	gamma-Aminobutyric Acid (GABA)IBA 07/2005
1	Baclofen FDA LinkGeneric 07/2005
1	methyl bromide (bromomethane)IBA 07/2005
1	Methysergide (Sansert)FDA Link 01/2003
1	Urethane (Ethyl Carbamate)IBA 09/2002
1	Angiotensin IIIBA 09/2002

Therapy/Procedure

3	Injections 08/2015 - 01/2003
3	Controlled Hypotension 08/2007 - 05/2000